Holen Sie sich die Stockscreener-App
0.5851
0.36%
0.0021
Handel nachbörslich:
.59
0.0049
+0.84%
Schlusskurs vom Vortag:
$0.583
Offen:
$0.577
24-Stunden-Volumen:
228.07K
Relative Volume:
0.38
Marktkapitalisierung:
$28.40M
Einnahmen:
$19.94M
Nettoeinkommen (Verlust:
$-37.37M
KGV:
-0.5626
EPS:
-1.04
Netto-Cashflow:
$-33.38M
1W Leistung:
-11.56%
1M Leistung:
-11.63%
6M Leistung:
-57.29%
1J Leistung:
-48.68%
1-Tages-Spanne:
$0.5538
$0.5856
1-Wochen-Bereich:
$0.5416
$0.69
52-Wochen-Spanne:
$0.5301
$2.38
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Firmenname
Werewolf Therapeutics Inc
Sektor
Branche
Telefon
617-952-0555
Adresse
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.5851 | 28.30M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.27 | 123.47B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
766.66 | 83.60B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
748.72 | 46.83B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.65 | 43.11B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
297.04 | 34.79B | 5.36B | 287.73M | 924.18M | 2.5229 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-19 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-04-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-08-24 | Eingeleitet | Wedbush | Outperform |
| 2023-06-06 | Fortgesetzt | Jefferies | Buy |
| 2021-09-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-25 | Eingeleitet | Evercore ISI | Outperform |
| 2021-05-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-05-25 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Werewolf Therapeutics Inc Aktie (HOWL) Neueste Nachrichten
HOWL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Is now the right time to enter Werewolf Therapeutics IncTrade Entry Report & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
HOWL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Werewolf Therapeutics Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Werewolf Therapeutics announces plan to explore strategic alternatives - MSN
Werewolf Therapeutics explores sale and strategic alternatives - Investing.com India
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives - Investing News Network
Werewolf Therapeutics Begins Strategic Alternatives Review Process - TipRanks
Werewolf Therapeutics (HOWL) starts review of strategic options with Piper Sandler - Stock Titan
Werewolf Therapeutics explores sale and strategic alternatives By Investing.com - Investing.com South Africa
Levels Update: Does Werewolf Therapeutics Inc have strong EBITDA marginsJuly 2025 Spike Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
HOWL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Published on: 2026-02-18 21:12:16 - baoquankhu1.vn
Why Werewolf Therapeutics Inc. stock could rally in 2025Portfolio Gains Summary & Smart Swing Trading Techniques - mfd.ru
IPO Launch: Does Werewolf Therapeutics Inc have strong EBITDA margins2025 Analyst Calls & Risk Controlled Daily Plans - baoquankhu1.vn
Werewolf Therapeutics stock falls after announcing 64% workforce reduction By Investing.com - Investing.com Canada
Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives - Asianet Newsable
Werewolf Therapeutics stock rises over 5% after hours on workforce reduction, including executives - MSN
Werewolf Therapeutics stock falls after announcing 64% workforce reduction - Investing.com
Werewolf Therapeutics Cuts 64% of Workforce - marketscreener.com
Werewolf Therapeutics Announces Major Workforce and Leadership Restructuring - TipRanks
Werewolf Therapeutics, Inc. Announces Executive Changes, Effective February 13, 2026 - marketscreener.com
What insider trading reveals about Werewolf Therapeutics Inc. stockMarket Movers & Verified Momentum Stock Ideas - mfd.ru
What is the target price for Werewolf Therapeutics Inc. stock2025 AllTime Highs & Risk Controlled Stock Pick Alerts - mfd.ru
Is Werewolf Therapeutics Inc. impacted by rising ratesWeekly Investment Report & Safe Capital Investment Plans - mfd.ru
Aug Opening: Should I invest in Standard BioTools Inc before earningsWall Street Watch & AI Powered Market Trend Analysis - baoquankhu1.vn
Does Werewolf Therapeutics Inc. have strong EBITDA marginsJuly 2025 Final Week & Daily Stock Trend Watchlist - mfd.ru
Death Cross: Is now the right time to enter Werewolf Therapeutics Inc2025 Geopolitical Influence & Consistent Income Trade Ideas - baoquankhu1.vn
Werewolf Therapeutics (HOWL) upgraded to buy: Here's what you should know - MSN
Trading Action: Does Werewolf Therapeutics Inc have strong EBITDA marginsJuly 2025 Momentum & AI Driven Stock Price Forecasts - baoquankhu1.vn
Werewolf Therapeutics receives Nasdaq notice for minimum bid price deficiency - Investing.com Nigeria
Werewolf Therapeutics Receives Nasdaq Minimum Bid Price Notice - TipRanks
Werewolf Therapeutics Received Notice of Noncompliance - TradingView
Bond Watch: What dividend growth rate does ZENA offerInsider Buying & Weekly Momentum Stock Picks - baoquankhu1.vn
Is Werewolf Therapeutics Inc stock trending bullish2025 Market Sentiment & Free Verified High Yield Trade Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock By Investing.com - Investing.com Australia
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock - Investing.com
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Update - Defense World
Movement Recap: Can Black Hawk Acquisition Corporation ride the EV waveGlobal Markets & Growth Focused Entry Point Reports - baoquankhu1.vn
Werewolf Therapeutics (HOWL) price target decreased by 10.86% to 5.30 - MSN
Evenin Luke sells Werewolf Therapeutics (HOWL) stock for $61k By Investing.com - Investing.com India
Evenin Luke sells Werewolf Therapeutics (HOWL) stock for $61k - Investing.com
Luke Evnin Sells 24,678 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - Defense World
Growth Value: Can Werewolf Therapeutics Inc stock double in next 5 yearsPortfolio Performance Report & Expert Curated Trade Setup Alerts - Bộ Nội Vụ
Finanzdaten der Werewolf Therapeutics Inc-Aktie (HOWL)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.71%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):